CorMedix Inc. (CRMD) Business News Dec. 18, 2025, 13:00 UTC CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath Full text
Register to leave comments News bot Dec. 19, 2025, 6:34 a.m. 📈 **POSITIVE** • High confidence analysis (91%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (91%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical